Bands in Peripheral Blood After Coronary Artery Bypass Grafting With and Without Cardiopulmonary Bypass

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00563030
Recruitment Status : Completed
First Posted : November 26, 2007
Last Update Posted : November 3, 2009
Information provided by:
Medical University of Gdansk

Brief Summary:

Coronary artery bypass graft (CABG) surgery is associated with reperfusion syndrome and activation of inflammatory reaction (SIRS). These are more exaggerated when cardiopulmonary bypass (CPB) is used.

The aim of the study is to compare signs of SIRS (heart rate, tachypnea or hypocarbia, leukocytosis, hyperpyrexia or hypothermia) and the granulocytes subsets in peripheral blood from patients who underwent CABG surgery with or without use of CPB.

The researchers expect significant differences in SIRS criteria between both groups. If the differences will occur significant, the parameter may be used as candidate variable for a complications prediction model after CABG surgery.

Condition or disease
Granulocyte Immature Forms Inflammatory Response Syndrome, Systemic

Detailed Description:

Patients fulfilling inclusion criteria will be asked to sign the consent to participate in the study, the day before operation after routine preoperative anesthesiological evaluation. If included into the study they will be assigned to one of the two study groups - off-pump CABG, or CABG with CPB.

After arrival into the operating theatre 4.5 ml blood will be obtained into EDTA vials from a peripheral venous canula, placed previously for routine anesthesiologic management.

Additional blood samples will be obtained 3, 6, 12, 24 and 48 hours after the operation. Each vial will be immediately labeled with an identification number and submitted into the laboratory, where smear with May-Grunwald-Giemsa staining will be prepared. The smear will be panoptical examined for 400 consecutive leucocytes and assigned to one of the following lines: neutrophils, eosinophils, basophils, monocytes and lymphocytes. Neutrophils will be further divided into: segments, bands, metamyelocytes, myelocytes, promyelocytes, myeloblasts.

The laboratory staff will be blinded for type of operation. Differences in subsets of granulocytes between groups and timepoints wil be analysed as means by appropriate parametric or nonparametric statistical tests.

The SIRS criteria will be refered to:

  1. Intraoperative variables: number of distal anastomoses, time of aorta/artery clamping, time of intraoperative hypotension, suction pump use, serum lactates;
  2. Postoperative variables: serum CRP, blood products transfusion, chest tube drainage.

Study Type : Observational
Actual Enrollment : 44 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: Comparison of Granulocyte Subsets in Peripheral Blood After Coronary Bypass Grafting Operations With and Without Use of Cardiopulmonary Bypass
Study Start Date : December 2007
Primary Completion Date : April 2009
Study Completion Date : May 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Patients undergoing CABG with CPB
Patients undergoing off-pump CABG

Primary Outcome Measures :
  1. percentage of immature forms of neutrophils in peripheral blood [ Time Frame: first 48 hours after operation ]

Secondary Outcome Measures :
  1. clinical signs of SIRS: heart rate, temperature, pCO2, respiratory rate (as applicable), total white blood cells [ Time Frame: first 48 hours after operation ]

Biospecimen Retention:   Samples Without DNA
blood on EDTA vials for automatical morphology analysis and manual blood-smear preparation.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients qualified for elective CABG with or without cardiopulmonary bypass. If possible, patient will be matched by age, sex, left ventricle ejection fraction, number of grafts, and major comorbidities (diabetes mellitus, arteriosclerosis).

Inclusion Criteria:

  • Elective or urgent CABG with CPB or without (off-pump CABG)
  • Signed informed consent

Exclusion Criteria:

  • Denied consent
  • Signs of infection and/or inflammation (at least 2/4 SIRS criteria)
  • Emergency operation
  • Organ failure/dysfunction

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00563030

Medical University of Gdańsk, Dept. of Cardiac Anesthesiology
Gdańsk, Poland, 80-211
Sponsors and Collaborators
Medical University of Gdansk
Study Director: Maciej M Kowalik, MD, PhD Medical University of Gdańsk, Dept. of Cardiac Anesthesiology

Additional Information:
Responsible Party: Maciej M. Kowalik MD, PhD, Medical University of Gdańsk Identifier: NCT00563030     History of Changes
Other Study ID Numbers: AMG-NKEBN/272/2007
First Posted: November 26, 2007    Key Record Dates
Last Update Posted: November 3, 2009
Last Verified: November 2009

Keywords provided by Medical University of Gdansk:
Cardiopulmonary bypass
Coronary artery bypass graft surgery

Additional relevant MeSH terms:
Systemic Inflammatory Response Syndrome
Pathologic Processes